Case number 1:18-cv-01005
Celgene Corporation v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (53) |
| Oct 5, 2018 | 7 | Patent/Trademark Report to Commissioner (2) |
| Oct 5, 2018 | 7 | Notice of Dismissal (1) |
| Oct 5, 2018 | 7 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,962,940 B2; 7,208,516 B2; 7,427,638 B2; 7,659,302 B2; 7,893,101 B2; 8,455,536 B2; 8,802,717 B2; 9,018,243 B2; 9,872,854 B2. (Attachments: # (1) Notice of Dismissal)(nms) |
| Oct 4, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [6]. (nms) |
| Oct 4, 2018 | 6 | Notice (Other) (1) Docket Text: NOTICE of Dismissal by Celgene Corporation (Blumenfeld, Jack) |
| Jul 11, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 9, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 7/9/2018; Aurobindo Pharma U.S.A., Inc. on 7/9/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (jcs) |
| Jul 6, 2018 | 1 | Exhibit A-J (293) |
| Jul 6, 2018 | 1 | Civil Cover Sheet (2) |
| Jul 6, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) |
| Jul 6, 2018 | 3 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See attached. (jcs) |
| Jul 6, 2018 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/29/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/21/2021. (jcs) |
| Jul 6, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Celgene Corporation. (jcs) |
| Jul 6, 2018 | 1 | Main Document (53) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2415352.) - filed by Celgene Corporation. (Attachments: # (1) Exhibit A-J, # (2) Civil Cover Sheet)(jcs) |
| Jul 6, 2018 | 1 | Complaint* (1) |
